 "Remdesivir")
The Indian government, on Wednesday, claimed it has ramped up the production of Remdesivir, an anti-viral drug prescribed for treating moderate-to-critical Covid patients, by 10 times. From 1 million vials per month in April, the Centre claims it will produce 10 million vials this month, as it has increased the number of plants manufacturing Remdesivir from 20 to 60.
Meanwhile, reports suggest that Remdesivir may soon be dropped from the Indian Council of Medical Research’s Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment. The news comes just days after plasma therapy was dropped from ICMR’s Covid
